Annual FCF
-$31.09 M
-$4.45 M-16.71%
31 December 2023
Summary:
Lumos Pharma annual free cash flow is currently -$31.09 million, with the most recent change of -$4.45 million (-16.71%) on 31 December 2023. During the last 3 years, it has fallen by -$1.42 million (-4.77%).LUMO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$5.01 M
+$1.37 M+21.54%
30 September 2024
Summary:
Lumos Pharma quarterly free cash flow is currently -$5.01 million, with the most recent change of +$1.37 million (+21.54%) on 30 September 2024. Over the past year, it has increased by +$2.39 million (+32.29%).LUMO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$31.67 M
+$2.81 M+8.16%
30 September 2024
Summary:
Lumos Pharma TTM free cash flow is currently -$31.67 million, with the most recent change of +$2.81 million (+8.16%) on 30 September 2024. Over the past year, it has dropped by -$578.00 thousand (-1.86%).LUMO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +32.3% | -1.9% |
| 3 y3 years | -4.8% | +13.8% | -6.8% |
| 5 y5 years | -242.0% | -83.2% | -248.4% |
LUMO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -129.0% | -103.8% | -128.5% |
Lumos Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.01 M(-21.5%) | -$31.67 M(-8.2%) |
| June 2024 | - | -$6.38 M(-50.5%) | -$34.49 M(-0.9%) |
| Mar 2024 | - | -$12.89 M(+74.4%) | -$34.79 M(+11.9%) |
| Dec 2023 | -$31.09 M(+16.7%) | -$7.39 M(-5.5%) | -$31.09 M(+5.3%) |
| Sept 2023 | - | -$7.82 M(+17.0%) | -$29.53 M(+8.5%) |
| June 2023 | - | -$6.68 M(-27.3%) | -$27.23 M(-2.0%) |
| Mar 2023 | - | -$9.20 M(+57.9%) | -$27.79 M(+4.4%) |
| Dec 2022 | -$26.64 M(-10.2%) | -$5.83 M(+5.6%) | -$26.62 M(+0.1%) |
| Sept 2022 | - | -$5.52 M(-23.8%) | -$26.61 M(-5.4%) |
| June 2022 | - | -$7.25 M(-9.8%) | -$28.14 M(+3.2%) |
| Mar 2022 | - | -$8.03 M(+38.2%) | -$27.27 M(-8.0%) |
| Dec 2021 | -$29.68 M(+28.9%) | -$5.81 M(-17.5%) | -$29.65 M(-3.8%) |
| Sept 2021 | - | -$7.05 M(+10.5%) | -$30.83 M(+31.8%) |
| June 2021 | - | -$6.38 M(-38.7%) | -$23.39 M(-22.4%) |
| Mar 2021 | - | -$10.41 M(+48.9%) | -$30.13 M(+30.8%) |
| Dec 2020 | -$23.03 M(+153.3%) | -$6.99 M(-1897.4%) | -$23.03 M(+22.7%) |
| Sept 2020 | - | $389.00 K(-103.0%) | -$18.77 M(-10.8%) |
| June 2020 | - | -$13.11 M(+296.2%) | -$21.04 M(+106.0%) |
| Mar 2020 | - | -$3.31 M(+21.1%) | -$10.21 M(+12.4%) |
| Dec 2019 | -$9.09 M(-76.0%) | -$2.73 M(+44.9%) | -$9.09 M(+18.5%) |
| Sept 2019 | - | -$1.89 M(-17.5%) | -$7.67 M(-63.1%) |
| June 2019 | - | -$2.29 M(+4.5%) | -$20.80 M(-18.3%) |
| Mar 2019 | - | -$2.19 M(+66.0%) | -$25.46 M(-32.9%) |
| Dec 2018 | -$37.95 M(-21.5%) | -$1.32 M(-91.2%) | -$37.95 M(-29.5%) |
| Sept 2018 | - | -$15.01 M(+116.2%) | -$53.84 M(+17.1%) |
| June 2018 | - | -$6.94 M(-52.7%) | -$45.97 M(-8.0%) |
| Mar 2018 | - | -$14.68 M(-14.7%) | -$49.96 M(+3.4%) |
| Dec 2017 | -$48.32 M | -$17.21 M(+141.0%) | -$48.32 M(+0.0%) |
| Sept 2017 | - | -$7.14 M(-34.6%) | -$48.30 M(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$10.93 M(-16.2%) | -$54.47 M(-11.4%) |
| Mar 2017 | - | -$13.04 M(-24.1%) | -$61.45 M(-9.9%) |
| Dec 2016 | -$68.19 M(+142.8%) | -$17.19 M(+29.2%) | -$68.19 M(+13.8%) |
| Sept 2016 | - | -$13.30 M(-25.7%) | -$59.90 M(+9.1%) |
| June 2016 | - | -$17.91 M(-9.5%) | -$54.90 M(+22.5%) |
| Mar 2016 | - | -$19.79 M(+122.4%) | -$44.82 M(+59.6%) |
| Dec 2015 | -$28.08 M(-126.2%) | -$8.90 M(+7.2%) | -$28.08 M(-125.3%) |
| Sept 2015 | - | -$8.30 M(+6.0%) | $111.14 M(+1.1%) |
| June 2015 | - | -$7.83 M(+156.4%) | $109.88 M(-0.5%) |
| Mar 2015 | - | -$3.05 M(-102.3%) | $110.47 M(+2.9%) |
| Dec 2014 | $107.37 M(-494.7%) | $130.32 M(-1464.2%) | $107.37 M(-445.0%) |
| Sept 2014 | - | -$9.55 M(+31.9%) | -$31.12 M(+7.9%) |
| June 2014 | - | -$7.24 M(+17.5%) | -$28.85 M(+8.1%) |
| Mar 2014 | - | -$6.16 M(-24.6%) | -$26.68 M(-1.9%) |
| Dec 2013 | -$27.20 M(+24.8%) | -$8.17 M(+12.1%) | -$27.20 M(+5.1%) |
| Sept 2013 | - | -$7.29 M(+43.8%) | -$25.88 M(+17.7%) |
| June 2013 | - | -$5.07 M(-24.2%) | -$21.98 M(-0.7%) |
| Mar 2013 | - | -$6.68 M(-2.4%) | -$22.13 M(+1.5%) |
| Dec 2012 | -$21.79 M(+64.7%) | -$6.85 M(+102.3%) | -$21.79 M(+30.1%) |
| Sept 2012 | - | -$3.38 M(-35.1%) | -$16.75 M(-0.6%) |
| June 2012 | - | -$5.21 M(-17.9%) | -$16.85 M(+10.9%) |
| Mar 2012 | - | -$6.35 M(+251.6%) | -$15.20 M(+14.9%) |
| Dec 2011 | -$13.23 M(-18.3%) | -$1.81 M(-48.1%) | -$13.23 M(+15.8%) |
| Sept 2011 | - | -$3.48 M(-2.3%) | -$11.42 M(+43.8%) |
| June 2011 | - | -$3.56 M(-18.8%) | -$7.95 M(+81.2%) |
| Mar 2011 | - | -$4.38 M | -$4.38 M |
| Dec 2010 | -$16.20 M(+53.7%) | - | - |
| Dec 2009 | -$10.54 M(+13.2%) | - | - |
| Dec 2008 | -$9.31 M | - | - |
FAQ
- What is Lumos Pharma annual free cash flow?
- What is the all time high annual FCF for Lumos Pharma?
- What is Lumos Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Lumos Pharma?
- What is Lumos Pharma quarterly FCF year-on-year change?
- What is Lumos Pharma TTM free cash flow?
- What is the all time high TTM FCF for Lumos Pharma?
- What is Lumos Pharma TTM FCF year-on-year change?
What is Lumos Pharma annual free cash flow?
The current annual FCF of LUMO is -$31.09 M
What is the all time high annual FCF for Lumos Pharma?
Lumos Pharma all-time high annual free cash flow is $107.37 M
What is Lumos Pharma quarterly free cash flow?
The current quarterly FCF of LUMO is -$5.01 M
What is the all time high quarterly FCF for Lumos Pharma?
Lumos Pharma all-time high quarterly free cash flow is $130.32 M
What is Lumos Pharma quarterly FCF year-on-year change?
Over the past year, LUMO quarterly free cash flow has changed by +$2.39 M (+32.29%)
What is Lumos Pharma TTM free cash flow?
The current TTM FCF of LUMO is -$31.67 M
What is the all time high TTM FCF for Lumos Pharma?
Lumos Pharma all-time high TTM free cash flow is $111.14 M
What is Lumos Pharma TTM FCF year-on-year change?
Over the past year, LUMO TTM free cash flow has changed by -$578.00 K (-1.86%)